Key facts
- It has raised $970K; the latest was Early Stage VC ($970K) in Feb 2025.
- Notable investors include Voyagers Capital (China).
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Alpine Medical (Shanghai)
- ·The full record, as it builds
Funding rounds
No funding rounds for Alpine Medical (Shanghai) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Alpine Medical (Shanghai)
Developer of ventricular assist devices designed to treat heart failure. The company develops percutaneous ventricular assist devices (pVAD) designed to be more affordable and providing shorter term support to patients, enabling providers to prescribe more accessible treatments to patients.
- Sector
- Healthcare
- HQ
- Shanghai, China
- Founded
- 2024
- Ownership
- Privately Held (backing)
Alpine Medical (Shanghai) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Alpine Medical (Shanghai) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Alpine Medical (Shanghai) in its N-PORT filings yet. We sweep new filings monthly.